In the current study, we applied an in-depth proteomic profiling of secretomes and extracellular vesicles (EVs) of BRCA1 -deficient and -proficient breast tumor cell lines derived from three validated GEMMs. The gene discussed is BRCA1; the disease is breast neoplasm.